IL1RL1 and obesity disorder: However, in pathological conditions such as obesity and cardiovascular disorders, both adipocytes and cardiac cells release larger amount of sST2; this functions as a decoy receptor, sequestering IL-33, losing its cardio-fat protection properties through ST2L binding, and consequently promoting an increase in fat mass, and heart damage [14,16,19,22].